Related Experiment Video
Updated: Jun 26, 2025

07:58
Cell-Free DNA Integrity Analysis in Urine Samples
Published on: January 5, 2017
13.8K
Characterization of extrachromosomal circular DNAs in plasma of patients with clear cell renal cell carcinoma
Qing Li1, Rui-Xuan Zhang1, Jing-Jing Yang1
1Clinical Laboratory, The First Affiliated Hospital of Wannan Medical College, No.2, West Zheshan Road, Wuhu, 241001, Anhui, China.
World Journal of Urology
|May 16, 2024
Summary
Researchers identified and characterized extrachromosomal circular DNAs (eccDNAs) in the blood of clear cell renal cell carcinoma (ccRCC) patients. Up-regulated eccDNAs show potential as a non-invasive biomarker for ccRCC diagnosis.
Area of Science:
- Molecular Biology
- Genomics
- Cancer Research
Background:
- Extrachromosomal circular DNAs (eccDNAs) play roles in biological processes.
- The presence and characteristics of eccDNA in clear cell renal cell carcinoma (ccRCC) patient plasma are uncharacterized.
- This study aimed to identify potential plasma eccDNA markers in ccRCC.
Purpose of the Study:
- To identify and characterize plasma eccDNAs in ccRCC patients.
- To compare plasma eccDNA profiles between ccRCC patients and healthy controls.
- To screen for plasma eccDNAs with diagnostic value for ccRCC.
Main Methods:
- Plasma eccDNA was detected using Tn5-tagmentation and next-generation sequencing (NGS).
- Comparisons included eccDNA length distribution, gene annotation, junctional nucleotide motif patterns, and expression.
- Statistical analyses were performed to identify differentially expressed eccDNAs.
Main Results:
- 8,568 plasma eccDNAs were found in ccRCC patients and 8,150 in controls.
- No significant differences in length, gene annotation, or motif signature were observed between groups.
- 701 differentially expressed eccDNAs were identified, with 25 showing potential diagnostic value for ccRCC, originating from tumor-associated genes.
Conclusions:
- Plasma eccDNAs were characterized in ccRCC patients.
- Up-regulated plasma eccDNAs are proposed as promising non-invasive biomarkers for ccRCC.
- Further research may validate these eccDNAs for clinical diagnostic applications.

